EVIO

EVIO Liabilities

The The Liabilities of EVIO (EVIO) as of Oct 26, 2026 is 13.70 M USD. In the previous year, The Liabilities was 19.79 M USD — a change of -30.75% (lower).

Liabilities

13.70 MUSD

YoY

-30.75%

Last updated:

In 2022, EVIO's total liabilities amounted to 13.70 M USD, a -30.75% difference from the 19.79 M USD total liabilities in the previous year.

The EVIO Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2015
443,435.00 USD
Jan 1, 2016
2.59 M USD
Jan 1, 2017
5.79 M USD
Jan 1, 2018
10.41 M USD
Jan 1, 2019
10.41 M USD
Jan 1, 2020
24.10 M USD
Jan 1, 2021
19.79 M USD
Jan 1, 2022
13.70 M USD
The EVIO Liabilities history
YEARLiabilitiesYoY
13.70 MUSD-30.75%
19.79 MUSD-17.91%
24.10 MUSD+131.46%
10.41 MUSD0.00%
10.41 MUSD+79.75%
5.79 MUSD+123.39%
2.59 MUSD+484.75%
443,435.00USD+687.78%
56,289.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EVIO Stock analysis

What does EVIO do? EVIO, Inc. generates revenue through analytical testing services for cannabis and hemp products, targeting agricultural and pharmaceutical industries. The company operates subsidiaries including Smith Scientific Industries, LLC, Greenhaus Analytical Labs, LLC, and Viridis Analytics, LLC, which provide testing to verify regulatory compliance for product sales. Residential and commercial construction services form another revenue stream, while research and development and consulting services cater to cannabis and hemp industry participants. Subsidiaries such as EVIO Labs OR, Inc., C3 Labs, LLC, and EVIO Labs Humboldt, LLC further support the company's service offerings. The primary customers for EVIO's testing services are businesses within the cannabis and hemp sectors requiring regulatory verification. Construction services are sold to residential and commercial clients, while R&D and consulting services target industry participants seeking expertise. Subsidiaries like Keystone Labs, Inc. contribute to the analytical testing segment, ensuring compliance with market requirements. EVIO's revenue model relies on multiple service lines across different industry segments without relying on external partnerships or third-party platforms. EVIO's service portfolio includes analytical testing, construction, and consulting, with all operations managed through its subsidiaries. The company's focus on regulatory compliance for cannabis and hemp products drives demand for its testing services. Construction services provide additional revenue, while R&D and consulting support industry growth. Subsidiaries such as Smith Scientific Industries, LLC and Greenhaus Analytical Labs, LLC operate under the EVIO brand to deliver specialized services to clients in the agricultural and pharmaceutical sectors. EVIO is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing EVIO's Liabilities

EVIO's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating EVIO's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing EVIO's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

EVIO's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in EVIO’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about EVIO stock

The Liabilities of EVIO is 13.70 M USD in 2022.

The Liabilities of EVIO changed from 19.79 M USD to 13.70 M USD, representing a -30.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities EVIO since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's EVIO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — EVIO

All Key Metrics — EVIO